Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern 3 Vct Regulatory News (NTN)

Share Price Information for Northern 3 Vct (NTN)

Share Price is delayed by 15 minutes
Get Live Data
81.00    0.00 (0.00%)
Bid:
79.50
Ask:
82.50
Spread: 3.00 (3.774%)
Market Cap: £144.04m
NTN Live PriceLast checked at - London Stock Exchange

Intraday Northern 3 Vct Share Chart

Net Asset Value

18 Feb 2019 15:45



Net Asset Value

18 FEBRUARY 2019

NORTHERN 3 VCT PLC

UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2018

Northern 3 VCT PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 2001 and managed by NVM Private Equity LLP. The Company’s objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

The unaudited net asset value per ordinary share as at 31 December 2018 was 92.5 pence (30 September 2018 94.6 pence). The net asset value is stated before deducting the interim dividend of 2.0 pence per share in respect of the year ending 31 March 2019, which was paid to eligible shareholders on 25 January 2019.

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 31 December 2018 and unquoted investments are carried at fair value as at 31 December 2018 as determined by the directors.

During the three months ended 31 December 2018 the following venture capital transactions took place:

New investments:

Name of company Business activity Amount invested £000
AdministrateSaaS training and learning management platform720
ThanksboxEmployee engagement platform provider384

Subsequent to 31 December 2018 the Company has completed a new investment of £528,000 in Life’s Great Group (trading as Mojo Mortgages), an online mortgage broking platform.

Realisations:

 SaleOriginalCarrying value at
Name of company proceeds cost 31 March 2018
 £000£000£000
Closerstill Group – sale of company 2,639 1,520 1,985
Lanner Group – loan stock repayment 32 32 32
Sinclair Pharma (AIM quoted) – agreed takeover 1,147 957 672

Subsequent to 31 December 2018 the Company has completed the sale of its holding in Lanner Group, generating proceeds of £434,000 compared to a residual holding cost of £187,000.

The number of ordinary shares in issue at 31 December 2018 was 89,238,957. During the three months ended 31 December 2018 403,275 shares were re-purchased for cancellation at a price of 88.5 pence per share.

Enquiries:Simon John/James Bryce, NVM Private Equity LLP – 0191 244 6000

Website: www.nvm.co.uk

Neither the contents of the NVM Private Equity LLP website nor the contents of any website accessible from hyperlinks on the NVM Private Equity LLP website (or any other website) is incorporated into, or forms part of, this announcement.


Date   Source Headline
5th Sep 20258:02 amGNWIssue of Equity and Total Voting Rights
1st Sep 20257:00 amGNWTotal voting rights
27th Aug 20251:00 pmGNWTransaction in Own Shares
8th Aug 20257:00 amGNWNet Asset Value(s)
7th Aug 20254:00 pmGNWResult of AGM
31st Jul 202511:00 amGNWTotal voting rights
25th Jul 20257:00 amGNWAnnual Financial Report and Notice of AGM
3rd Jul 20257:00 amGNWTransaction in Own Shares
30th Jun 202511:00 amGNWTotal voting rights
17th Jun 20254:30 pmGNWAnnual Report and Financial Statements for the year ended 31 March 2025
17th Jun 20254:30 pmGNWStatement regarding intention to fundraise
17th Jun 20254:30 pmGNWDividend Declaration
30th May 20257:00 amGNWTotal voting rights
30th Apr 202511:00 amGNWTotal voting rights
25th Apr 20257:00 amGNWNon-Executive Director Appointment
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202511:00 amGNWDirector/PDMR Dealings
3rd Apr 202510:00 amGNWIssue of Equity and Total Voting Rights
31st Mar 202511:00 amGNWTotal voting rights
24th Mar 20254:30 pmGNWTransaction in Own Shares
28th Feb 202511:00 amGNWTotal voting rights
25th Feb 20259:00 amGNWOffer for subscription update
6th Feb 20258:00 amGNWNet Asset Value
31st Jan 202511:00 amGNWTotal voting rights
22nd Jan 20258:00 amGNWIssue of Equity and Total Voting Rights
17th Jan 20254:15 pmGNWTransaction in Own Shares
14th Jan 20258:00 amGNWOffer for subscription
9th Jan 20252:00 pmGNWPublication of Prospectus
31st Dec 202411:00 amGNWTotal voting rights
4th Dec 20248:00 amGNWTransaction in Own Shares
29th Nov 202411:00 amGNWTotal voting rights
21st Nov 20243:00 pmGNWHalf-yearly report
21st Nov 20242:01 pmGNWDividend Declaration
21st Nov 20242:00 pmGNWUnaudited Half-Yearly Financial Report for the Six Months Ended 30 September 2024
31st Oct 202411:00 amGNWTotal voting rights
30th Sep 202411:00 amGNWTotal voting rights
26th Sep 20248:00 amGNWTransaction in Own Shares
23rd Sep 202410:00 amGNWStatement regarding intention to fundraise
30th Aug 202411:00 amGNWTotal voting rights
23rd Aug 20248:00 amGNWIssue of Equity and Total Voting Rights
12th Aug 20243:30 pmGNWTransaction in Own Shares
2nd Aug 20248:00 amGNWNet Asset Value
1st Aug 20244:00 pmGNWResult of AGM
31st Jul 202411:00 amGNWTotal voting rights
5th Jul 20248:00 amGNWTransaction in Own Shares
28th Jun 20243:00 pmGNWAnnual Report and Notice of AGM
28th Jun 202411:00 amGNWTotal voting rights
18th Jun 20243:01 pmGNWDividend Declaration
18th Jun 20243:00 pmGNWANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.